Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 3
2008 5
2009 3
2010 6
2011 4
2012 2
2013 6
2014 9
2015 11
2016 12
2017 11
2018 4
2019 6
2020 5
2021 6
2022 5
2023 4
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms.
Diamond EL, Durham BH, Haroche J, Yao Z, Ma J, Parikh SA, Wang Z, Choi J, Kim E, Cohen-Aubart F, Lee SC, Gao Y, Micol JB, Campbell P, Walsh MP, Sylvester B, Dolgalev I, Aminova O, Heguy A, Zappile P, Nakitandwe J, Ganzel C, Dalton JD, Ellison DW, Estrada-Veras J, Lacouture M, Gahl WA, Stephens PJ, Miller VA, Ross JS, Ali SM, Briggs SR, Fasan O, Block J, Héritier S, Donadieu J, Solit DB, Hyman DM, Baselga J, Janku F, Taylor BS, Park CY, Amoura Z, Dogan A, Emile JF, Rosen N, Gruber TA, Abdel-Wahab O. Diamond EL, et al. Among authors: park cy. Cancer Discov. 2016 Feb;6(2):154-65. doi: 10.1158/2159-8290.CD-15-0913. Epub 2015 Nov 13. Cancer Discov. 2016. PMID: 26566875 Free PMC article.
SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition.
Kim E, Ilagan JO, Liang Y, Daubner GM, Lee SC, Ramakrishnan A, Li Y, Chung YR, Micol JB, Murphy ME, Cho H, Kim MK, Zebari AS, Aumann S, Park CY, Buonamici S, Smith PG, Deeg HJ, Lobry C, Aifantis I, Modis Y, Allain FH, Halene S, Bradley RK, Abdel-Wahab O. Kim E, et al. Among authors: park cy. Cancer Cell. 2015 May 11;27(5):617-30. doi: 10.1016/j.ccell.2015.04.006. Cancer Cell. 2015. PMID: 25965569 Free PMC article.
BRAF-mutant hematopoietic malignancies.
Abdel-Wahab O, Park CY. Abdel-Wahab O, et al. Among authors: park cy. Oncotarget. 2014 Sep 30;5(18):7980-1. doi: 10.18632/oncotarget.2448. Oncotarget. 2014. PMID: 25478626 Free PMC article. No abstract available.
Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression.
Cimmino L, Dolgalev I, Wang Y, Yoshimi A, Martin GH, Wang J, Ng V, Xia B, Witkowski MT, Mitchell-Flack M, Grillo I, Bakogianni S, Ndiaye-Lobry D, Martín MT, Guillamot M, Banh RS, Xu M, Figueroa ME, Dickins RA, Abdel-Wahab O, Park CY, Tsirigos A, Neel BG, Aifantis I. Cimmino L, et al. Among authors: park cy. Cell. 2017 Sep 7;170(6):1079-1095.e20. doi: 10.1016/j.cell.2017.07.032. Epub 2017 Aug 17. Cell. 2017. PMID: 28823558 Free PMC article.
Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma.
Chao MP, Alizadeh AA, Tang C, Myklebust JH, Varghese B, Gill S, Jan M, Cha AC, Chan CK, Tan BT, Park CY, Zhao F, Kohrt HE, Malumbres R, Briones J, Gascoyne RD, Lossos IS, Levy R, Weissman IL, Majeti R. Chao MP, et al. Among authors: park cy. Cell. 2010 Sep 3;142(5):699-713. doi: 10.1016/j.cell.2010.07.044. Cell. 2010. PMID: 20813259 Free PMC article.
(Reg)ulation of hematopoietic lineage fates.
Sreejit G, Park CY. Sreejit G, et al. Among authors: park cy. Blood. 2024 Jan 18;143(3):188-190. doi: 10.1182/blood.2023023000. Blood. 2024. PMID: 38236614 No abstract available.
Loss of Notch signaling in skeletal stem cells enhances bone formation with aging.
Remark LH, Leclerc K, Ramsukh M, Lin Z, Lee S, Dharmalingam B, Gillinov L, Nayak VV, El Parente P, Sambon M, Atria PJ, Ali MAE, Witek L, Castillo AB, Park CY, Adams RH, Tsirigos A, Morgani SM, Leucht P. Remark LH, et al. Among authors: park cy. Bone Res. 2023 Sep 27;11(1):50. doi: 10.1038/s41413-023-00283-8. Bone Res. 2023. PMID: 37752132 Free PMC article.
Pathogenic Mechanisms in Acute Myeloid Leukemia.
Chakraborty S, Park CY. Chakraborty S, et al. Among authors: park cy. Curr Treat Options Oncol. 2022 Nov;23(11):1522-1534. doi: 10.1007/s11864-022-01021-8. Epub 2022 Oct 3. Curr Treat Options Oncol. 2022. PMID: 36190670 Review.
IL-34: a novel differentiation therapy for AML?
Roy N, Park CY. Roy N, et al. Among authors: park cy. Blood. 2023 Jun 29;141(26):3130-3132. doi: 10.1182/blood.2023020525. Blood. 2023. PMID: 37383007 No abstract available.
101 results